USV has invested in Daybreak, a pediatric mental health platform leveraging school infrastructure to provide timely and scalable mental health care for students.
Information on the Target
USV has made significant strides in addressing the mental health crisis, particularly focusing on the needs of children and adolescents. One of their key investments is Daybreak, a leading pediatric mental health platform designed to operate within the existing infrastructure of schools and districts. The platform aims to provide timely support for students struggling with mental health issues while also developing scalable solutions for proactive care that benefits all students. Daybreak is dedicated to creating personalized treatment plans that foster meaningful outcomes, ensuring that care is collaborative among students, schools, and parents.
Industry Overview in the United States
The mental health landscape in the United States has faced unprecedented challenges, especially among children and adolescents. The COVID-19 pandemic has exacerbated existing mental health issues, with a reported 16% of children experiencing at least one major depressive episode in the past year. Alarmingly, 60% of these children do not receive appropriate treatment, highlighting a significant gap in care that needs to be addressed.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Schools have emerged as critical players in the mental health support ecosystem, as they are uniquely positioned to identify students in need of assistance. Educators understand the links between mental health, academic performance, and ov
Similar Deals
New Markets Venture Partners → Knack
2025
WestBridge Capital → Yoodli
2025
Emerson Collective → Syndio
2023
The Stephens Group → Accredible
2023
Lumos Capital Group → Transfr
2023
USV
invested in
Daybreak
in 2023
in a Series B deal